NS Pharma is working to have an important impact on the lives of patients with rare diseases. Our therapeutic areas encompass neurological diseases and inflammatory diseases.
Harnessing the power of innovative science can help bring new treatments to patients with rare diseases. NS Pharma is developing therapies through exon-skipping, cell therapy and JAK1 inhibition technology.
NS Pharma is working to have an important impact on the lives of patients with rare diseases. Our therapeutic areas encompass neurological diseases and inflammatory diseases.
Harnessing the power of innovative science can help bring new treatments to patients with rare diseases. NS Pharma is developing therapies through exon-skipping, cell therapy and JAK1 inhibition technology.
Press Release / April 18, 2025
FDA Grants Orphan Drug Designation to NS-229 for the Treatment of Eosinophilic Granulomatosis with Polyangiitis
Press Release / April 18, 2025
FDA Grants Orphan Drug Designation to NS-229 for the Treatment of Eosinophilic Granulomatosis with Polyangiitis
A warm #Welcome to Heather Greenberg, our new Associate Director of the Patient Services Hub!
Heather brings 20+ years of expertise in patient access and reimbursement, notably in #RareDiseases! Outside of work, she's a passionate runner and beach lover.
#NewHire #GrowingTeam https://x.com/NSPharmaInc/status/1920849518288891947/photo/1
Meet Ross, our new Director of Market Access Marketing!
Ross brings 20+ years of pharma commercial leadership experience across sales, operations, marketing, and market access. When he’s not at work, he enjoys spending time with his family.
#Welcome to the team!
#NewHire https://x.com/NSPharmaInc/status/1919754533720281572/photo/1
We are proud to be joining @REGENXBIO as a Visionary sponsor of the 2025 @Projectalive Building A Future Together MPS II Community Conference this weekend, bringing together members of the Hunter syndrome community for a day of learning, connection and fun. Hope to see you there! https://x.com/NSPharmaInc/status/1918322518185873656/photo/1
Join our growing team at NS Pharma! 🚀
We're excited to announce an opening for an Associate Director of Regulatory Affairs, Strategy.
Want to make a significant impact in the pharmaceutical industry? Apply here: https://ow.ly/5eN550VHEhK
#Hiring #PharmaCareers #JobOpportunity https://x.com/NSPharmaInc/status/1918304715642753287/photo/1
NS Pharma is thrilled to continue our journey with the #Duchenne community by sponsoring another @CureDuchenne Community Dinner.
📍 Location: True Foods, San Diego
🕒 Time: 6:00PM - 9:00PM PT
Secure your place at the table: https://ow.ly/lgxV50VFw1R
#CureDuchenneCares https://x.com/NSPharmaInc/status/1915767757037019295/photo/1
We’re thrilled to announce our sponsorship of the upcoming #JettFoundationFamilyWorkshop this Saturday in Iowa City!
This workshop is a fantastic opportunity to connect with specialists, share experiences, and gain insights that empower the #DuchenneCommunity.
See you there! https://x.com/NSPharmaInc/status/1915043616902234170/photo/1
